This country profile provides an overview of Madagascar’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
15%
Blinding trachoma
N/A
Intestinal worms
53%
Bilharzia
66%
River blindness
N/A
7.6 million
people received treatment in Madagascar in 2019
13.53 million
people did not receive treatment in Madagascar in 2019
Elephantiasis
Treatment coverage was not reported in 2018 and 15% in 2019.
People needing treatment
21.13m
People receiving treatment
3.13m
Blinding trachoma
Madagascar does not require mass treatment for blinding trachoma.
Intestinal worms
Treatment coverage increased from 0% in 2018 to 53% in 2019.
Pre-sch and school-aged children needing treatment
8.12m
Pre-school and school-aged children receiving treatment
4.33m
Bilharzia
Treatment coverage increased from 0% in 2018 to 66% in 2019.
School-aged children needing treatment
4.32m
School-aged children receiving treatment
2.84m
River blindness
Madagascar does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Madagascar.